相似文献
1
New Developments in the Treatment of Hepatocellular Carcinoma: The Concept of Adjuvant and Neoadjuvant Chemotherapy.
J Clin Exp Hepatol. 2021 May-Jun;11(3):284-287. doi: 10.1016/j.jceh.2021.04.003. Epub 2021 Apr 27.
2
Radiofrequency and microwave ablation in combination with transarterial chemoembolization induce equivalent histopathologic coagulation necrosis in hepatocellular carcinoma patients bridged to liver transplantation.
Hepatobiliary Surg Nutr. 2016 Jun;5(3):225-33. doi: 10.21037/hbsn.2016.01.05.
3
Radiofrequency vs Microwave Ablation After Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular Carcinoma.
Curr Probl Diagn Radiol. 2017 Nov-Dec;46(6):402-409. doi: 10.1067/j.cpradiol.2017.02.006. Epub 2017 Feb 20.
4
The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma.
Anal Cell Pathol (Amst). 2019 Aug 26;2019:8619096. doi: 10.1155/2019/8619096. eCollection 2019.
5
Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysis.
Int J Hyperthermia. 2022;39(1):455-465. doi: 10.1080/02656736.2022.2048095.
6
Radiofrequency ablation or microwave ablation combined with transcatheter arterial chemoembolization in treatment of hepatocellular carcinoma by comparing with radiofrequency ablation alone.
Chin J Cancer Res. 2014 Feb;26(1):112-8. doi: 10.3978/j.issn.1000-9604.2014.02.09.
7
Comparison of combined transarterial chemoembolization and ablations in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Abdom Radiol (NY). 2022 Mar;47(3):1009-1023. doi: 10.1007/s00261-021-03368-2. Epub 2022 Jan 4.
8
Current status of the combination therapy of transarterial chemoembolization and local ablation for hepatocellular carcinoma.
Abdom Radiol (NY). 2019 Jun;44(6):2268-2275. doi: 10.1007/s00261-019-01943-2.
9
Microwave ablation and synchronous transarterial chemoembolization combined with PD-1 inhibitor in patients with hepatocellular carcinoma following tyrosine kinase inhibitor intolerance.
Front Immunol. 2023 Jan 10;13:1097625. doi: 10.3389/fimmu.2022.1097625. eCollection 2022.
10
Transarterial Chemoembolization Combined with Either Radiofrequency or Microwave Ablation in Management of Hepatocellular Carcinoma.
Asian Pac J Cancer Prev. 2017 Jan 1;18(1):189-194. doi: 10.22034/APJCP.2017.18.1.189.
引用本文的文献
1
FCGR2A contributes to M2 macrophages polarization in HCC through IL-4/JAK/STAT6 axis.
Transl Oncol. 2025 Aug;58:102429. doi: 10.1016/j.tranon.2025.102429. Epub 2025 Jun 6.
2
Local-region treatment comparison following conversion therapy of hepatocellular carcinoma: a period and age-dependent analysis.
Ther Adv Med Oncol. 2025 Mar 19;17:17588359251316665. doi: 10.1177/17588359251316665. eCollection 2025.
3
Efficacy and safety of neoadjuvant therapy for hepatocellular carcinoma with portal vein thrombosis: A meta‑analysis.
Oncol Lett. 2025 Jan 7;29(3):122. doi: 10.3892/ol.2025.14868. eCollection 2025 Mar.
4
2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations.
J Clin Exp Hepatol. 2024 Jan-Feb;14(1):101269. doi: 10.1016/j.jceh.2023.08.005. Epub 2023 Aug 19.
5
Hepatocellular Carcinoma: Surveillance, Diagnosis, Evaluation and Management.
Cancers (Basel). 2023 Oct 24;15(21):5118. doi: 10.3390/cancers15215118.
6
Ephrin-A4 Ligand (EFNA4) Predicts Poor Prognosis of Hepatocellular Carcinoma and Promotes Tumor Proliferation.
J Clin Exp Hepatol. 2023 Sep-Oct;13(5):767-773. doi: 10.1016/j.jceh.2023.04.004. Epub 2023 Apr 15.
7
Comprehensive Review of Hepatocellular Carcinoma in India: Current Challenges and Future Directions.
JCO Glob Oncol. 2022 Oct;8:e2200118. doi: 10.1200/GO.22.00118.
8
Treatment for Hepatocellular Carcinoma in South Asia.
J Clin Exp Hepatol. 2021 Nov-Dec;11(6):641-645. doi: 10.1016/j.jceh.2021.09.018. Epub 2021 Sep 24.
本文引用的文献
1
Percutaneous Cryoablation of Liver Tumors: Initial Experience from a Tertiary Care Center in India.
J Clin Exp Hepatol. 2021 May-Jun;11(3):305-311. doi: 10.1016/j.jceh.2020.10.005. Epub 2020 Oct 19.
2
Role of N-acetyl Cysteine in Post-transarterial Chemoembolization Transaminitis in Hepatocellular Carcinoma: A Single-center Experience.
J Clin Exp Hepatol. 2021 May-Jun;11(3):299-304. doi: 10.1016/j.jceh.2020.10.007. Epub 2020 Oct 27.
3
Recent Advances in Systemic Therapy for Hepatocellular Carcinoma in an Aging Society: 2020 Update.
Liver Cancer. 2020 Dec;9(6):640-662. doi: 10.1159/000511001. Epub 2020 Nov 17.
4
Perspectives on the Neoadjuvant Use of Immunotherapy in Hepatocellular Carcinoma.
Hepatology. 2021 Jul;74(1):483-490. doi: 10.1002/hep.31697. Epub 2021 Jun 28.
5
Current State of Combination of Locoregional Therapies with Immune Checkpoint Inhibition.
J Vasc Interv Radiol. 2020 Nov;31(11):1740-1744.e9. doi: 10.1016/j.jvir.2020.07.011. Epub 2020 Oct 2.
6
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial.
Clin Cancer Res. 2020 Oct 1;26(19):5140-5152. doi: 10.1158/1078-0432.CCR-20-1695. Epub 2020 Jul 14.
7
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
N Engl J Med. 2020 May 14;382(20):1894-1905. doi: 10.1056/NEJMoa1915745.
8
Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial.
Lancet Oncol. 2020 Jun;21(6):786-795. doi: 10.1016/S1470-2045(20)30140-6. Epub 2020 May 7.
9
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.
J Clin Exp Hepatol. 2020 Jan-Feb;10(1):43-80. doi: 10.1016/j.jceh.2019.09.007. Epub 2019 Sep 23.
10
Role of locoregional therapies in the wake of systemic therapy.
J Hepatol. 2020 Feb;72(2):277-287. doi: 10.1016/j.jhep.2019.09.023.
Zotero 插件